| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Department of Pathobiology, University of Pennsylvania, Philadelphia, PA 19104; and
Department of Molecular Microbiology, Washington University School of Medicine, St Louis, MO 63110
Long-term immunity to Leishmania may require the continued presence of parasites, but previous attempts to create attenuated parasites that persist without causing disease have had limited success. Since Leishmania major mutants that lack lipophosphoglycan and other secreted phosphoglycans, termed lpg2-, persist indefinitely in infected mice without inducing any disease, we tested their ability to provide protection to virulent L. major challenge. In response to leishmanial Ag stimulation, cells from lpg2--infected mice produced minimal levels of IL-4 and IL-10, as well as very low levels of IFN-
. Nevertheless, when BALB/c mice infected with lpg2- parasites were challenged with virulent L. major they were protected from disease. Thus, these findings report on attenuated parasites that may be used to induce long-term protection against leishmaniasis and indicate that the immunity induced can be maintained in the absence of a strong Th1 response.
This article has been cited by other articles:
|
|
 |
|
  A. A. Capul, S. Hickerson, T. Barron, S. J. Turco, and S. M. Beverley Comparisons of Mutants Lacking the Golgi UDP-Galactose or GDP-Mannose Transporters Establish that Phosphoglycans Are Important for Promastigote but Not Amastigote Virulence in Leishmania major Infect. Immun., September 1, 2007; 75(9): 4629 - 4637. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Silvestre, A. Cordeiro-Da-Silva, N. Santarem, B. Vergnes, D. Sereno, and A. Ouaissi SIR2-Deficient Leishmania infantum Induces a Defined IFN-{gamma}/IL-10 Pattern That Correlates with Protection J. Immunol., September 1, 2007; 179(5): 3161 - 3170. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Boitz and B. Ullman A Conditional Mutant Deficient in Hypoxanthine-guanine Phosphoribosyltransferase and Xanthine Phosphoribosyltransferase Validates the Purine Salvage Pathway of Leishmania donovani J. Biol. Chem., June 9, 2006; 281(23): 16084 - 16089. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Naderer, M. A. Ellis, M. F. Sernee, D. P. De Souza, J. Curtis, E. Handman, and M. J. McConville Virulence of Leishmania major in macrophages and mice requires the gluconeogenic enzyme fructose-1,6-bisphosphatase PNAS, April 4, 2006; 103(14): 5502 - 5507. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Kebaier, J. E. Uzonna, S. M. Beverley, and P. Scott Immunization with Persistent Attenuated {Delta}lpg2 Leishmania major Parasites Requires Adjuvant To Provide Protective Immunity in C57BL/6 Mice Infect. Immun., January 1, 2006; 74(1): 777 - 780. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Breton, M. J Tremblay, M. Ouellette, and B. Papadopoulou Live Nonpathogenic Parasitic Vector as a Candidate Vaccine against Visceral Leishmaniasis Infect. Immun., October 1, 2005; 73(10): 6372 - 6382. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. S. Tabbara, N. C. Peters, F. Afrin, S. Mendez, S. Bertholet, Y. Belkaid, and D. L. Sacks Conditions Influencing the Efficacy of Vaccination with Live Organisms against Leishmania major Infection Infect. Immun., August 1, 2005; 73(8): 4714 - 4722. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. F. Spath, L.-F. Lye, H. Segawa, S. J. Turco, and S. M. Beverley Identification of a Compensatory Mutant (lpg2-REV) of Leishmania major Able To Survive as Amastigotes within Macrophages without LPG2-Dependent Glycoconjugates and Its Significance to Virulence and Immunization Strategies Infect. Immun., June 1, 2004; 72(6): 3622 - 3627. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
